These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 6303587)
1. Cyclophosphamide, vincristine, lomustine, cisplatin, and doxorubicin in the treatment of non-small cell lung cancer. Pearlman NW; Meyers TJ; Siebert PE; Wallner SF; Carson SD; Campbell DN; Johnson FB; Kennaugh R; Rempel P Cancer Treat Rep; 1983 Apr; 67(4):375-6. PubMed ID: 6303587 [TBL] [Abstract][Full Text] [Related]
2. Use of cisplatin, cyclophosphamide, vincristine, and doxorubicin for the treatment of non-small cell lung cancer. Lindgren D; Cadman E; Erichson R; Grann V; Sachs K Cancer Treat Rep; 1984 Sep; 68(9):1159-61. PubMed ID: 6090015 [TBL] [Abstract][Full Text] [Related]
3. [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung]. Sanz Ortiz J; Saiz GarcĂa F Med Clin (Barc); 1982 Nov 16-30; 79(9):403-6. PubMed ID: 6296560 [No Abstract] [Full Text] [Related]
4. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations. Aisner J; Whitacre M; Van Echo DA; Wiernik PH Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987 [TBL] [Abstract][Full Text] [Related]
5. Cisplatin and etoposide alternating with vincristine, doxorubicin and cyclophosphamide in patients with small cell lung cancer. Littlewood TJ; Smith AP; Anderson G; Chappell AG; James KW Eur J Respir Dis; 1985 Oct; 67(4):294-300. PubMed ID: 3000808 [TBL] [Abstract][Full Text] [Related]
6. Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer. Kelsen D; Gralla R; Stoopler M; Casper E; Cheng E; Kosloff C; Golbey R Cancer Treat Rep; 1982 Feb; 66(2):247-51. PubMed ID: 7034932 [TBL] [Abstract][Full Text] [Related]
7. Combined modality treatment of small cell carcinoma of the lung. Feld R; Pringle JF; Evans WK; Keen CW; Quirt IC; Curtis JE; Baker MA; Yeoh JL; Deboer G; Brown TC Arch Intern Med; 1981 Mar; 141(4):469-73. PubMed ID: 6260048 [TBL] [Abstract][Full Text] [Related]
8. Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancers. Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK Cancer Treat Rep; 1981; 65(5-6):453-8. PubMed ID: 6263477 [TBL] [Abstract][Full Text] [Related]
9. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma. Evans WK; Feld R; DeBoer G; Osoba D; Curtis JE; Baker MA; Myers RE; Quirt IC; Pritchard KI; Brown TC; Kutas GJ; Blackstein ME; Ottema B; Millband L Cancer Treat Rep; 1981; 65(11-12):947-54. PubMed ID: 7028256 [TBL] [Abstract][Full Text] [Related]
10. Single-agent and combination chemotherapy for extensive non-small cell carcinomas of the lung. Davis S; Pandya MR; Rambotti P Cancer Treat Rep; 1980; 64(4-5):685-8. PubMed ID: 6253067 [TBL] [Abstract][Full Text] [Related]
11. Cisplatin, doxorubicin, cyclophosphamide, lomustine, and vincristine (PACCO) in the treatment of non-small cell bronchogenic carcinoma. Whitehead RP; Rosenbaum PR; Carbone PP Cancer Treat Rep; 1984 May; 68(5):771-3. PubMed ID: 6539171 [TBL] [Abstract][Full Text] [Related]
13. Treatment of small cell lung cancer with cyclophosphamide, adriamycin and vincristine (CAV) combination therapy: experience at University Hospital, Kuala Lumpur, Malaysia. Lee SM Singapore Med J; 1990 Aug; 31(4):317-20. PubMed ID: 2175049 [TBL] [Abstract][Full Text] [Related]
14. [Cisplatin, peplomycin, mitomycin C, and vincristine combination chemotherapy of non-small cell carcinoma of the lung]. Saito H; Nomura F; Kawatsu H; Sakai S; Kobayashi T; Shimokata K Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2715-8. PubMed ID: 6210062 [TBL] [Abstract][Full Text] [Related]
15. Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study. Krook JE; Fleming TR; Eagan RT; Cullinan S; Pfeifle D; Elliott T; Etzell P Cancer Treat Rep; 1984 Mar; 68(3):493-8. PubMed ID: 6322987 [TBL] [Abstract][Full Text] [Related]
16. Scheduled and unscheduled combination chemotherapy in the treatment of squamous cell lung cancer (cyclophosphamide, adriamycin, vincristine and bleomycin, with and without cis-platinum). Jones DH; Bleehen NM; Grant RM; Plowman PN; Roberts JT; Sikora K; Watson JV; Wiltshire CR Anticancer Res; 1983; 3(4):235-8. PubMed ID: 6192751 [TBL] [Abstract][Full Text] [Related]
17. Intensive induction therapy for small cell carcinoma of the lung. Abeloff MD; Ettinger DS; Khouri NF; Lenhard RE Cancer Treat Rep; 1979 Apr; 63(4):519-24. PubMed ID: 221117 [TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for small cell bronchogenic carcinoma: CCNU and doxorubicin compared to CCNU, doxorubicin, vincristine, and procarbazine. Vogelzang NJ; Trowbridge RC; Frenning DH; Theologides A; Kennedy BJ; Kelly DR; Ewing SL; Vosika GJ Cancer Treat Rep; 1980; 64(8-9):997-1000. PubMed ID: 6256076 [TBL] [Abstract][Full Text] [Related]
19. Three-drug chemotherapy combined with radiation therapy in small cell carcinoma of the lung. Sibille Y; Steyaert J; Francis C; Bosly A; Prignot J Eur J Respir Dis; 1983 Feb; 64(2):113-20. PubMed ID: 6299770 [TBL] [Abstract][Full Text] [Related]
20. cis-Dichlorodiammineplatinum(II), adriamycin, cyclophosphamide, CCNU, and vincristine in non-small cell lung carcinoma: a preliminary report. Takita H; Marabella PC; Edgerton F; Rizzo D Cancer Treat Rep; 1979 Jan; 63(1):29-33. PubMed ID: 369692 [No Abstract] [Full Text] [Related] [Next] [New Search]